Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Interest in how the gut microbiome can influence the metabolic state of the host has recently heightened. One postulated link is bacterial fermentation of “indigestible” prebiotics to short-chain fatty acids (SCFAs), which in turn modulate the release of gut hormones controlling insulin release and appetite. We show here that SCFAs trigger secretion of the incretin hormone glucagon-like peptide (GLP)-1 from mixed colonic cultures in vitro. Quantitative PCR revealed enriched expression of the SCFA receptors ffar2 (grp43) and ffar3 (gpr41) in GLP-1–secreting L cells, and consistent with the reported coupling of GPR43 to Gq signaling pathways, SCFAs raised cytosolic Ca2+ in L cells in primary culture. Mice lacking ffar2 or ffar3 exhibited reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and a parallel impairment of glucose tolerance. These results highlight SCFAs and their receptors as potential targets for the treatment of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2. SCFAs raise intracellular calcium in identified colonic L cells. A: Mixed colonic cultures were loaded with fura2-AM. Pseudocolor images of fura2 340:380 nm fluorescence ratio (reflecting [Ca2+]i) shown prior to (basal) and during the application of propionate (1 mmol/L), and after washing with saline. B: Identification of an L cell in the field of view shown in A identified by the fluorescence of Venus (475 nm excitation). C: A representative response of an L and a non–L cell recorded as in A. D: Mean calcium changes in L cells (filled bars) and non–L cells (open bars) after the addition of acetate (1 mmol/L), propionate (1 mmol/L), or CFMB (30 μmol/L) as indicated. Ratios (340:380) in the presence of the test agent were normalized to the mean of the background ratios of each cell measured before addition and after washout of the test compound. Data represent the means ± SEM of the number of cells indicated above each bar. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with baseline and ##P < 0.01 and ###P < 0.001 compared with non–L cells by Student t test. (A high-quality digital representation of this figure is available in the online issue.)](https://figures.cochat.ai/paper-figures/c242c8ac43cc4c669f03082b05300a60/short-chain-fatty-acids-stimulate-glucagon-like-peptide-1-secretion-via-the-g-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFA-induced activation of receptors on enteroendocrine cells can promote gut-brain signaling by inducing hormones such as glucagon-like peptide 1 (GLP1) and peptide YY (PYY), as well as neurotransmitters like GABA and serotonin (276).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [276]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rodent-based studies also suggest that SCFAs may influence gut motility [57], suppress appetite (through enhanced incretin [glucagon-like peptide-1, GLP-1] release) and enhance insulin sensitivity [58].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in rodents show that the administration of prebiotics that influences a shift in the gut microbiome toward increased production of butyrate has beneficial effects associated with higher levels of GLP-1 (193–195), as well as hypothalamic expression of pro-opiomelanocortin (196), thereby influencing the hunger-satiety cycle.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [193]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs can stimulate the secretion of GLP-1 and PYY through the FFAR2 and, to a lesser extent, the FFAR3 receptor (Lin et al., 2012;Psichas et al., 2015;Tolhurst et al., 2012).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Tolhurst et al., 2012
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, SCFA can stimulate the release of GLP-1 in vitro and in vivo dependently of the FFA receptor 2 (Figure 1) [237].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [237]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Topping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564
Glucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · cited 8×
“Secreted and cellular GLP-1 was extracted as previously described (24), and active GLP-1 was quantified by ELISA (Millipore).”
MethodInfluentialSelf-citationXiong, Y., Miyamoto, N., Shibata, K., Valasek, M. A., Motoike, T., Kedzierski, R. M., & Yanagisawa, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2637002100 · Cited by 731
Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man
EISSELE, R., GÖKE, R., WILLEMER, S., HARTHUS, H. ‐., VERMEER, H., ARNOLD, R., & GÖKE, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01464.x · Cited by 654
Acetate and Propionate Short Chain Fatty Acids Stimulate Adipogenesis via GPCR43
Hong, Y.-H., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C., Choi, K.-C., Feng, D. D., Chen, C., Lee, H.-G., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0545 · Cited by 612
Cited by
Items 801–900 of 1,015
Peng, J., Li, X., Zheng, L., Duan, L., Gao, Z., Hu, D., Li, J., Li, X., Shen, X., & Xiao, H. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s352863 · Cited by 51
Influence of the gut microbiota on satiety signaling
Bastings, J. J. A. J., Venema, K., Blaak, E. E., & Adam, T. C. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.02.003 · Cited by 50
Corriero, A., Giglio, M., Inchingolo, F., Moschetta, A., Varrassi, G., & Puntillo, F. (2023) · Pain and Therapy · doi:10.1007/s40122-023-00565-3 · Cited by 56
The immunity–diet–microbiota axis in the development of metabolic syndrome
Brandsma, E., Houben, T., Fu, J., Shiri-Sverdlov, R., & Hofker, M. H. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000154 · Cited by 50
Aw, W., & Fukuda, S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0456-2 · Cited by 55
Moran, B. M., Flatt, P. R., & McKillop, A. M. (2016) · Acta Diabetologica · doi:10.1007/s00592-015-0826-9 · Cited by 52
The regulation of function, growth and survival of GLP-1-producing L-cells
Kuhre, R. E., Holst, J. J., & Krizhanovskii, C. (2015) · Clinical Science · doi:10.1042/cs20150154 · Cited by 54
Aranias, T., Grosfeld, A., Poitou, C., Omar, A. A., Le Gall, M., Miquel, S., Garbin, K., Ribeiro, A., Bouillot, J.-L., Bado, A., et al. (2015) · Journal of Nutritional Science · doi:10.1017/jns.2015.11 · Cited by 48
Dusaulcy, R., Handgraaf, S., Skarupelova, S., Visentin, F., Vesin, C., Heddad-Masson, M., Reimann, F., Gribble, F., Philippe, J., & Gosmain, Y. (2016) · Endocrinology · doi:10.1210/en.2016-1433 · Cited by 48
Self-citationYan, Y., Hu, Y., & Gänzle, M. G. (2018) · Current Opinion in Food Science · doi:10.1016/j.cofs.2018.02.009 · Cited by 55
Oral administration of short chain fatty acids could attenuate fat deposition of pigs
Jiao, A., Diao, H., Yu, B., He, J., Yu, J., Zheng, P., Huang, Z., Luo, Y., Luo, J., Mao, X., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196867 · Cited by 52
An overview of energy and metabolic regulation
Wen, S., Wang, C., Gong, M., & Zhou, L. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9371-4 · Cited by 55
Liu, Y., Heath, A. M., Galland, B. C., Rehrer, N. J., Drummond, L., Wu, X., Bell, T. J., Lawley, B., Sims, I. M., & Tannock, G. W. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01905-19 · Cited by 55
van Trijp, M. P. H., Rösch, C., An, R., Keshtkar, S., Logtenberg, M. J., Hermes, G. D. A., Zoetendal, E. G., Schols, H. A., & Hooiveld, G. J. E. J. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000455 · Cited by 52
Eslami, M., Bahar, A., Hemati, M., Nejad, Z. R., Mehranfar, F., Karami, S., Kobyliak, N. M., & Yousefi, B. (2020) · Diabetic Medicine · doi:10.1111/dme.14415 · Cited by 50
Intestinal microbiota and their metabolic contribution to type 2 diabetes and obesity
Cunningham, A., Stephens, J. W., & Harris, D. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00858-4 · Cited by 51
McCarty, M. F., & DiNicolantonio, J. J. (2015) · Open Heart · doi:10.1136/openhrt-2014-000205 · Cited by 51
Incretin Hormones, Obesity and Gut Microbiota
Angelini, G., Russo, S., & Mingrone, G. (2024) · Peptides · doi:10.1016/j.peptides.2024.171216 · Cited by 47
Neuro-Signals from Gut Microbiota: Perspectives for Brain Glioma
D’Alessandro, G., Lauro, C., Quaglio, D., Ghirga, F., Botta, B., Trettel, F., & Limatola, C. (2021) · Cancers · doi:10.3390/cancers13112810 · Cited by 50
Communication between the gut microbiota and peripheral nervous system in health and chronic disease
Cook, T. M., & Mansuy‐Aubert, V. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2068365 · Cited by 49
Schlechte, J., Skalosky, I., Geuking, M. B., & McDonald, B. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00539-2 · Cited by 51
Lv, Q., Li, Z., Sui, A., Yang, X., Han, Y., & Yao, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.977187 · Cited by 59
The Role and Mechanism of Probiotics Supplementation in Blood Glucose Regulation: A Review
Shen, X., Ma, C., Yang, Y., Liu, X., Wang, B., Wang, Y., Zhang, G., Bian, X., & Zhang, N. (2024) · Foods · doi:10.3390/foods13172719 · Cited by 54
Cho, Y., Kim, S., Kim, P.-K., Jo, M. J., Park, S.-E., Choi, Y., Jung, S. M., & Kang, H. J. (2025) · Biomolecules · doi:10.3390/biom15020291 · Cited by 50
Sergeev, E., Hansen, A. H., Pandey, S. K., Mackenzie, A. E., Hudson, B. D., Ulven, T., & Milligan, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.687939 · Cited by 47
Kaji, I., Akiba, Y., Konno, K., Watanabe, M., Kimura, S., Iwanaga, T., Kuri, A., Iwamoto, K., Kuwahara, A., & Kaunitz, J. D. (2016) · The Journal of Physiology · doi:10.1113/jp271441 · Cited by 49
Gillard, L., Billiauws, L., Stan-Iuga, B., Ribeiro‐Parenti, L., Jarry, A., Cavin, J., Cluzeaud, F., Mayeur, C., Thomas, M., Freund, J., et al. (2016) · Scientific Reports · doi:10.1038/srep28345 · Cited by 53
Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases
Schiattarella, G. G., Sannino, A., Esposito, G., & Perrino, C. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.08.003 · Cited by 48
Hui, S., Huang, L., Wang, X., Zhu, X., Zhou, M., Chen, M., Yi, L., & Mi, M. (2020) · The FASEB Journal · doi:10.1096/fj.201902618rr · Cited by 50
Su, C., Chen, C., Jiao, L., Long, S. R., Mao, T., Ji, Q., O’Donnell, S. T., Stanton, C., Zheng, S., Walker, W. A., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.06.010 · Cited by 50
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Zhou, J., Tripathi, M., Sinha, R. A., Singh, B. K., & Yen, P. M. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.134 · Cited by 62
Zhao, G., Yang, L., Zhong, W., Hu, Y., Tan, Y., Ren, Z., Ban, Q., Yang, C. S., Wang, Y., & Wang, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.857879 · Cited by 55
Potential use of dietary fibre from Hibiscus sabdariffa and Agave tequilana in obesity management
Moyano, G., Sáyago‐Ayerdi, S. G., Largó, C., Caz, V., López-Santamaría, M., & Tabernero, M. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.11.011 · Cited by 76
Azcárate-Peril, M. A., Roach, J. M., Marsh, A. J., Chey, W. D., Sandborn, W. J., Ritter, A. J., Savaiano, D. A., & Klaenhammer, T. R. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1957536 · Cited by 56
Juan, Y., Chen, Y., & Xu, M. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109013 · Cited by 48
Chrono-exercise: Time-of-day-dependent physiological responses to exercise
Kim, H., Radak, Z. O., Takahashi, M., Inami, T., & Shibata, S. (2022) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2022.11.003 · Cited by 53
Yadav, H., Jaldhi, Bhardwaj, R., Anamika, A., Bakshi, A., Gupta, S., & Maurya, S. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122022 · Cited by 52
The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes
Ang, Z., Er, J. Z., & Ding, J. L. (2015) · Scientific Reports · doi:10.1038/srep08134 · Cited by 47
Loss of Free Fatty Acid Receptor 2 leads to impaired islet mass and beta cell survival
Villa, S. R., Priyadarshini, M., Fuller, M. H., Bhardwaj, T., Brodsky, M. R., Angueira, A. R., Mosser, R. E., Carboneau, L., Tersey, S. A., Mancebo, H. S. Y., et al. (2016) · Scientific Reports · doi:10.1038/srep28159 · Cited by 47
Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases
Marrone, M. C., & Coccurello, R. (2019) · Biomolecules · doi:10.3390/biom10010012 · Cited by 45
Metabolic and inflammatory functions of short-chain fatty acid receptors
Bolognini, D., Dedeo, D., & Milligan, G. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.06.005 · Cited by 52
Gesù, C. M. D., Matz, L. M., & Buffington, S. A. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.05.003 · Cited by 53
Zhang, Y., Li, X., Huang, G., Wang, H., Chen, H., Su, Y., Yu, K., & Zhu, W. (2022) · Animal nutrition · doi:10.1016/j.aninu.2022.06.003 · Cited by 51
Chen, S., Wang, J., Dong, N., Fang, Q., Zhang, Y. L., Chen, C., Cui, S. W., & Nie, S. (2023) · Food & Function · doi:10.1039/d2fo02555h · Cited by 47
Chen, K., Wang, H., Yang, Y., Tang, C., Sun, X., Zhou, J., Liu, S., Li, Q., Zhao, L., & Gao, Z. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02299-5 · Cited by 49
Rewiring the Brain Through the Gut: Insights into Microbiota–Nervous System Interactions
Săvulescu-Fiedler, I., Benea, S. N., Căruntu, C., Nancoff, A.-S., Homentcovschi, C., & Bucurica, S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070489 · Cited by 52
Enteroendocrine cells: the gatekeepers of microbiome-gut-brain communication
Grundeken, E., & Aidy, S. E. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00810-x · Cited by 55
Mârza, S. M., Munteanu, C., Papuc, I., Radu, L., & Purdoiu, R. C. (2025) · Animals · doi:10.3390/ani15202986 · Cited by 54
Duodenal luminal nutrient sensing
Rønnestad, I., Akiba, Y., Kaji, I., & Kaunitz, J. D. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.07.010 · Cited by 50
Gut microbiota in older subjects: variation, health consequences and dietary intervention prospects
O’Connor, E. M., O’Herlihy, E. A., & O’Toole, P. W. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114000597 · Cited by 48
The role of gut microbiota in nutritional status
O’Connor, E. M. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283638eb3 · Cited by 45
Anticancer effects of metformin on neuroendocrine tumor cells in vitro
Vlotides, G., Tanyeri, A., Spampatti, M. P., Zitzmann, K., Chourdakis, M., Spöttl, G., Maurer, J., Nölting, S., Göke, B., & Auernhammer, C. J. (2014) · HORMONES · doi:10.14310/horm.2002.1517 · Cited by 50
Lim, J. C. L., Henry, C. J., & Haldar, S. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600121 · Cited by 50
Olfactory Receptor OR51E1 Mediates GLP-1 Secretion in Human and Rodent Enteroendocrine L Cells
Han, Y. E., Kang, C. W., Oh, J. H., Park, S. H., Ku, C. R., Cho, Y. H., Lee, M. K., & Lee, E. J. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00165 · Cited by 47
Role of Gut Microbiota in Combating Oxidative Stress
Dam, B., Misra, A., & Banerjee, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-8763-0_4 · Cited by 49
Modasia, A., Parker, A., Jones, E., Stentz, R., Brion, A., Goldson, A., Defernez, M., Wileman, T., Ashley Blackshaw, L., & Carding, S. R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575595 · Cited by 46
The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea
Badran, M., Mashaqi, S., & Gozal, D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1841749 · Cited by 47
Dagbasi, A., Lett, A. M., Murphy, K., & Frost, G. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006941 · Cited by 44
Shabani, M., Ghoshehy, A., Mottaghi, A. M., Chegini, Z., Kerami, A., Shariati, A., & Moghadam, M. T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1516010 · Cited by 57
Chlorogenic Acid’s Role in Metabolic Health: Mechanisms and Therapeutic Potential
Zalewska, K., Kulawik, M., Gierszewska, J., Gramala, Z., Kalus, O., Karpiński, M., Maćkowiak, J., Staniewski, A., Szymańska, Z., Zalewska, B., et al. (2025) · Nutrients · doi:10.3390/nu17203303 · Cited by 54
Hayashi, H., Yamada, R., Das, S., Sato, T., Takahashi, A., Hiratsuka, M., & Hirasawa, N. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.012 · Cited by 48
Hindy, G., Mollet, I. G., Rukh, G., Ericson, U., & Orho‐Melander, M. (2016) · Genes & Nutrition · doi:10.1186/s12263-016-0524-4 · Cited by 46
Fluitman, K. S., de Clercq, N. C., Keijser, B. J. F., Visser, M., Nieuwdorp, M., & IJzerman, R. G. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1318060 · Cited by 49
Martin, W. P., Docherty, N. G., & le Roux, C. W. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1518130 · Cited by 49
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
Iruzubieta, P., Medina, J. M., Fernández-López, R., Crespo, J., & de la Cruz, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051369 · Cited by 46
Perspective: Prospects for Nutraceutical Support of Intestinal Barrier Function
McCarty, M. F., & Lerner, A. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa139 · Cited by 47
Krizhanovskii, C., Zhang, Q., Nyström, T., & Sjöholm, Å. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-70 · Cited by 46
Shackley, M., Ma, Y., Tate, E. W., Brown, A., Frost, G. S., & Hanyaloglu, A. C. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.568991 · Cited by 46
Progress on traditional Chinese medicine in treatment of ischemic stroke via the gut-brain axis
Zhai, Z., Su, P., Ma, L.-Y., Yang, H., Wang, T., Fei, Z.-G., Zhang, Y., Wang, Y., Ma, K., Han, B.-B., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114056 · Cited by 46
Rew, L., Harris, M. D., & Goldie, J. H. (2022) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v15i4.2600 · Cited by 72
Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis
Dong, C. X., & Brubaker, P. L. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.185 · Cited by 51
Tsuda, T. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400871 · Cited by 44
Bahar Halpern, K., Veprik, A., Rubins, N., Naaman, O., & Walker, M. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.358887 · Cited by 44
Wheeler, S. E., Stacey, H. M., Nahaei, Y., Hale, S. J., Hardy, A. B., Reimann, F. M., Gribble, F. M., Larraufie, P., Gaisano, H. Y., & Brubaker, P. L. (2017) · Diabetes · doi:10.2337/db16-1403 · Cited by 48
Self-citationDisruptions in gut microbial-host co-metabolism and the development of metabolic disorders
Rajani, C., & Jia, W. P. (2018) · Clinical Science · doi:10.1042/cs20171328 · Cited by 45
Csernus, B., & Czeglédi, L. (2020) · Archives animal breeding/Archiv für Tierzucht · doi:10.5194/aab-63-325-2020 · Cited by 47
The role of lactose in weanling pig nutrition: a literature and meta-analysis review
Zhao, J., Zhang, Z., Zhang, S., Page, G. L., & Jaworski, N. W. (2021) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-020-00522-6 · Cited by 43
Multiple Selection Criteria for Probiotic Strains with High Potential for Obesity Management
Alard, J., Cudennec, B., Boutillier, D., Peucelle, V., Descat, A., Decoin, R., Kuylle, S., Jablaoui, A., Rhimi, M., Wolowczuk, I., et al. (2021) · Nutrients · doi:10.3390/nu13030713 · Cited by 49
Wu, J.-T., Sun, C.-L., Lai, T.-T., Liou, C.-W., Lin, Y.-Y., Xue, J.-Y., Wang, H.-W., Chai, L. M. X., Lee, Y.-J., Chen, S., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109140 · Cited by 43
Yamane, S., Harada, N., & Inagaki, N. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12467 · Cited by 43
Intestinal nutrient sensing and blood glucose control
Zietek, T., & Daniel, H. (2015) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000187 · Cited by 48
Elsabagh, M., Inabu, Y., Obitsu, T., & Sugino, T. (2017) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2017.03.001 · Cited by 44
Lama, A., Annunziata, C., Coretti, L., Pirozzi, C., Guida, F., Izzo, A. N., Cristiano, C., Mollica, M. P., Chiariotti, L., Pelagalli, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41295-x · Cited by 57
Cheng, W., Lam, K., Kong, A. P. S., & Cheung, P. C. K. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109437 · Cited by 44
Martinez, T. M., Meyer, R. K., & Duca, F. A. (2021) · Nutrients · doi:10.3390/nu13103470 · Cited by 46
Keady, M., Prado, N. A., Lim, H. C., Brown, J. L., Paris, S., & Muletz‐Wolz, C. R. (2021) · Animal Microbiome · doi:10.1186/s42523-021-00146-9 · Cited by 46
Wang, S., Cui, Z., & Yang, H. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03255-y · Cited by 46
Impact of Gut Microbiota and SCFAs in the Pathogenesis of PCOS and the Effect of Metformin Therapy
Kukaev, E., Дмитриевна, К. Е., Tokareva, A., Rimskaya, E. N., Starodubtseva, N. L., Евгеньевна, Ч. Г., Priputnevich, T. V., Евгеньевич, Ф. В., & Sukhikh, G. T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910636 · Cited by 49
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin
Szymczak-Pajor, I., Drzewoski, J., Kozłowska, M., Krekora, J., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18010055 · Cited by 45
Regulation of gut hormone secretion. Studies using isolated perfused intestines
Svendsen, B., & Holst, J. J. (2015) · Peptides · doi:10.1016/j.peptides.2015.08.001 · Cited by 47
Host Energy Regulation via SCFAs Receptors, as Dietary Nutrition Sensors, by Gut Microbiota
Kimura, I. (2014) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00169 · Cited by 41
Eelderink, C., Noort, M. W. J., Sözer, N., Koehorst, M., Holst, J. J., Deacon, C. F., Rehfeld, J. F., Poutanen, K. S., Vonk, R. J., Oudhuis, L. A. A. C. M., et al. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1156-6 · Cited by 46
Shi, G., Sun, C., Gu, W., Yang, M., Zhang, X., Zhai, N., Lü, Y., Zhang, Z., Shou, P., Zhang, Z., et al. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0065 · Cited by 44
Gut Microbiota: FFAR Reaching Effects on Islets
Priyadarshini, M., Navarro, G., & Layden, B. T. (2018) · Endocrinology · doi:10.1210/en.2018-00296 · Cited by 41
Ghorbani, Y., Schwenger, K. J. P., & Allard, J. P. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02520-4 · Cited by 42
Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence
Dai, W., Liu, J., Yan, Q., Teng, Z., Li, S., Yuan, H., Huang, J., Xiang, H., Tang, H., Wang, B., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.893567 · Cited by 46
Probiotics and Gut Microbiota in Obesity: Myths and Realities of a New Health Revolution
Aguilera, X. L., Manzano, A., Pírela, D., & Bermúdez, V. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081282 · Cited by 52
Dietary fibers influence the intestinal SCFAs and plasma metabolites profiling in growing pigs
Wu, W., Xie, J., & Zhang, H. (2016) · Food & Function · doi:10.1039/c6fo01406b · Cited by 48
Mashaqi, S., & Gozal, D. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.03.020 · Cited by 40
A Bitter Aftertaste: Unintended Effects of Artificial Sweeteners on the Gut Microbiome
Bokulich, N. A., & Blaser, M. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.012 · Cited by 41
Metadata
- Authors
- Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M.
- Affiliations
- Addenbrooke's Hospital (GB)
- Takeda (United Kingdom) (GB)
- Corresponding author
- Reimann, Frank
- Gribble, Fiona M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-01-17
- Volume
- 61
- Issue
- 2
- Pages
- 364-371
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3266401
- OpenAlex
- W2168842536
- Cited by
- 2,404
- References
- 32
- Citations by year
- 2026: 266 · 2025: 233 · 2024: 203 · 2023: 183 · 2022: 245 · 2021: 205 · 2020: 215 · 2019: 151 · 2018: 158 · 2017: 120 · 2016: 132 · 2015: 103 · 2014: 92 · 2013: 65 · 2012: 27
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
- Apollo
- Funders
- Wellcome Trust (084210/Z/07/Z, 088357/Z/09/Z, #WT084210, 088357, 088357/Z/09/A)
- European Commission (2007–2013, 266408)
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- short-chain fatty acids, glucagon-like peptide-1, FFAR2, GPR43, GPR41, incretin secretion, gut microbiota, prebiotic fermentation, colonic epithelial cells, calcium signaling, glucose tolerance, diabetes treatment, Gq signaling
- MeSH terms
- Animals, Calcium, Colon, Fatty Acids, Volatile, Mice, Inbred C57BL, Signal Transduction, GTP-Binding Protein alpha Subunits, Gi-Go, Receptors, G-Protein-Coupled, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.